These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 28443356
1. Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis. Fadl Elmula FEM, Feng YM, Jacobs L, Larstorp AC, Kjeldsen SE, Persu A, Staessen JA, European Network COordinating research on Renal Denervation (ENCOReD). Blood Press; 2017 Aug; 26(4):195-203. PubMed ID: 28443356 [Abstract] [Full Text] [Related]
2. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension. Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium. Blood Press; 2015 Aug; 24(5):263-74. PubMed ID: 26194721 [Abstract] [Full Text] [Related]
3. Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials. Ogoyama Y, Abe M, Okamura K, Tada K, Katsurada K, Shibata S, Kai H, Rakugi H, Node K, Yokoi H, Kario K, Arima H. Hypertens Res; 2024 Oct; 47(10):2745-2759. PubMed ID: 38831091 [Abstract] [Full Text] [Related]
4. The effect of renal denervation on arterial stiffness, central blood pressure and heart rate variability in treatment resistant essential hypertension: a substudy of a randomized sham-controlled double-blinded trial (the ReSET trial). Peters CD, Mathiassen ON, Vase H, Bech Nørgaard J, Christensen KL, Schroeder AP, Rickers HJVH, Opstrup UK, Poulsen PL, Langfeldt S, Andersen G, Hansen KW, Bøtker HE, Engholm M, Bertelsen JB, Pedersen EB, Kaltoft A, Buus NH. Blood Press; 2017 Dec; 26(6):366-380. PubMed ID: 28830251 [Abstract] [Full Text] [Related]
5. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial. Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A. J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432 [Abstract] [Full Text] [Related]
6. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis. Fernandes A, David C, Pinto FJ, Costa J, Ferreira JJ, Caldeira D. BMC Cardiovasc Disord; 2023 May 12; 23(1):249. PubMed ID: 37173636 [Abstract] [Full Text] [Related]
7. Intravascular Renal Denervation Reduces Ambulatory and Office Blood Pressure in Patients with Essential Hypertension: A Meta-Analysis of Randomized Sham-Controlled Trials. Yang X, Liu H, Chen S, Dong P, Zhao D. Kidney Blood Press Res; 2022 May 12; 47(6):363-374. PubMed ID: 35385842 [Abstract] [Full Text] [Related]
8. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial. Wang J, Yin Y, Lu C, Lu Z, Hu J, Wang Y, Ge J, Jiang H, Yao C, Yan X, Ma W, Qi X, Dang Y, Chen S, Zhu J, Wang D, Ding C, Wang W, Liu J, Wang Y, Li H, Pan Z, Cui K, Li C, Liang X, Chen W, Sobotka PA, Zhang J, Esler M, Sun N, Chen M, Huo Y. EClinicalMedicine; 2024 Jun 12; 72():102626. PubMed ID: 38756107 [Abstract] [Full Text] [Related]
9. 2019 Consensus Statement of the Taiwan Hypertension Society and the Taiwan Society of Cardiology on Renal Denervation for the Management of Arterial Hypertension. Wang TD, Lee YH, Chang SS, Tung YC, Yeh CF, Lin YH, Pan CT, Hsu CY, Huang CY, Wu CK, Sung PH, Chiang LT, Wang YC, Tsai WC, Lin TT, Lin CP, Chen WJ, Hwang JJ. Acta Cardiol Sin; 2019 May 12; 35(3):199-230. PubMed ID: 31249454 [Abstract] [Full Text] [Related]
10. Effects of catheter-based renal denervation in hypertension: a systematic review and meta-analysis. Vukadinović D, Lauder L, Kandzari DE, Bhatt DL, Kirtane A, Edelman ER, Schmieder RE, Azizi M, Böhm M, Mahfoud F. medRxiv; 2024 Jun 17. PubMed ID: 38946962 [Abstract] [Full Text] [Related]
11. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension. Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C. Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527 [Abstract] [Full Text] [Related]
12. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial. de Jager RL, de Beus E, Beeftink MM, Sanders MF, Vonken EJ, Voskuil M, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY Investigators. Hypertension; 2017 Apr 15; 69(4):678-684. PubMed ID: 28264922 [Abstract] [Full Text] [Related]
13. Effectiveness of Renal Denervation in Resistant Hypertension: A Meta-Analysis of 11 Controlled Studies. Pappaccogli M, Covella M, Berra E, Fulcheri C, Di Monaco S, Perlo E, Burrello J, Monticone S, Rossato D, Rabbia F, Veglio F. High Blood Press Cardiovasc Prev; 2018 Jun 15; 25(2):167-176. PubMed ID: 29752703 [Abstract] [Full Text] [Related]
14. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study. Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S. Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375 [Abstract] [Full Text] [Related]
15. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial. Böhm M, Mahfoud F, Townsend RR, Kandzari DE, Pocock S, Ukena C, Weber MA, Hoshide S, Patel M, Tyson CC, Weil J, Agdirlioglu T, Fahy M, Kario K. Eur Heart J; 2019 Mar 01; 40(9):743-751. PubMed ID: 30608521 [Abstract] [Full Text] [Related]
17. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A. Hypertension; 2013 Sep 01; 62(3):526-32. PubMed ID: 23836798 [Abstract] [Full Text] [Related]
18. Renal denervation in moderate treatment-resistant hypertension. Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE. J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901 [Abstract] [Full Text] [Related]
19. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. Pathak A, Rudolph UM, Saxena M, Zeller T, Müller-Ehmsen J, Lipsic E, Schmieder RE, Sievert H, Halbach M, Sharif F, Parise H, Fischell TA, Weber MA, Kandzari DE, Mahfoud F. EuroIntervention; 2023 Sep 18; 19(7):602-611. PubMed ID: 37427416 [Abstract] [Full Text] [Related]
20. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence. Weber MA, Mahfoud F, Schmieder RE, Kandzari DE, Tsioufis KP, Townsend RR, Kario K, Böhm M, Sharp ASP, Davies JE, Osborn JW, Fink GD, Euler DE, Cohen DL, Schlaich MP, Esler MD. JACC Cardiovasc Interv; 2019 Jun 24; 12(12):1095-1105. PubMed ID: 31221299 [Abstract] [Full Text] [Related] Page: [Next] [New Search]